Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma

Ibrutinib effective treatment for difficult-to-treat forms of hairy cell leukemia, study finds

Study: Ibrutinib effective treatment for difficult to treat forms of hairy cell leukemia

Ibrutinib with rituximab in previously untreated CLL: indication of added benefit over FCR